We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest News

News

Expanded Access Program for Rexin-G™ Provides Genetic Medicine to Cancer Patients

The Expanded Access Program extends the clinical applications of the world's first targeted genetic medicine to many more cancer patients.
News

Industry Leaders and Investors Explore Better Business Models for the 'New Diagnostics' at Bio 2006

Experts will debate business models to support the growing potential of molecular diagnostics during a kick-off panel at BIO 2006.
News

Third Wave and Mitsubishi Announce Japanese Joint Venture for Personalized Medicine

Third Wave will accelerate and expand the development of high-value clinical products for the Japanese molecular diagnostic market.
News

Plexxikon Advances First Oncology Development Candidate

Preclinical data for oncogenic B-Raf inhibitor presented at American Association for Cancer Research Annual Meeting.
News

PerkinElmer and JMC Collaborate to Develop Molecular Diagnostics Screening Platforms

Partnership expected to advance capabilities in screening assays and discovery and validation of new biomarkers.
News

Upstream Completes Acquisition of Genetic Diagnostic Marker Company

As a result of the transaction, Upstream Canada is now a wholly-owned subsidiary of the Company.
News

Shimadzu, Toppan and Third Wave Sign Agreement for Point-of-Care Instrument

The instrument is designed to analyzing a patient's DNA for specific gene sequences.
News

Xenomics Appoints New CEO

Dr. L. David Tomei has been appointed as new CEO.
News

Ipsogen Presents Breast Cancer Biomarker Results at the EBCC 5

These results concern the identification on 323 patient samples.
News

Brain Cancer Patients Living Longer After Personalized Vaccine Therapy

Patients are surviving twice as long with DCVax®-Brain as with other therapeutics.
Advertisement